Valeant is laying off but others are hiring! Check it out! (Isn’t it tempting?)
Canada’s Valeant Pharmaceuticals International Inc , which has offered to buy Bausch & Lomb Holdings for $8.7 billion, said it may slash 10 to 15 percent of the combined company’s workforce. Valeant, which expects to get regulatory nod by early August, said severance plans for the United States and Canada have been finalized.
Don’t forget, hundreds of biopharma companies are hiring! (We know you can’t resist.)
